FOSCARNET SODIUM

FOSCARNET SODIUM was reported 4026 times

FOSCARNET SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ABIOTROPHIA DEFECTIVA ENDOCARDITIS 4 0.4444
1 ENCEPHALITIS CYTOMEGALOVIRUS 172 0.3927
2 ENDOCARDITIS HISTOPLASMA 3 0.2308
3 RETINITIS VIRAL 25 0.2066
4 FLAVOBACTERIUM INFECTION 9 0.2045
5 HAEMORRHAGIC PNEUMONIA 6 0.0968
6 BLOOD HIV RNA 5 0.0962
7 DISSEMINATED CYTOMEGALOVIRAL INFECTION 20 0.0926
8 BILIARY TRACT INFECTION BACTERIAL 2 0.0909
9 ADENOVIRAL HEPATITIS 21 0.0894
10 GRAFT VERSUS HOST DISEASE IN INTESTINE 11 0.0846
11 BK POLYOMAVIRUS TEST POSITIVE 8 0.0833
12 HUMAN HERPESVIRUS 6 ENCEPHALITIS 23 0.0810
13 VIRAL HAEMORRHAGIC CYSTITIS 53 0.0744
14 CYTOMEGALOVIRUS CHORIORETINITIS 138 0.0707
15 ADENOVIRUS REACTIVATION 10 0.0694
16 SCHIZENCEPHALY 3 0.0667
17 HYPOURICAEMIA 19 0.0655
18 EOSINOPHILIC PUSTULAR FOLLICULITIS 6 0.0645
19 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 19 0.0638
20 CYTOMEGALOVIRUS GASTRITIS 16 0.0632
21 TRACTIONAL RETINAL DETACHMENT 7 0.0631
22 VIRAL UVEITIS 6 0.0619
23 EPSTEIN-BARR VIRAEMIA 64 0.0577
24 HERPES SIMPLEX MENINGOENCEPHALITIS 5 0.0562
25 HIV WASTING SYNDROME 2 0.0556
26 CYTOMEGALOVIRUS INFECTION REACTIVATION 240 0.0543
27 EYE INFECTION FUNGAL 21 0.0543
28 BACTERIAL TOXAEMIA 7 0.0543
29 NEUTROPHIL MORPHOLOGY ABNORMAL 3 0.0526
30 RHEGMATOGENOUS RETINAL DETACHMENT 11 0.0526
31 CYTOMEGALOVIRUS VIRAEMIA 231 0.0519
32 AIDS ENCEPHALOPATHY 3 0.0517
33 NECROTISING RETINITIS 32 0.0500
34 PNEUMONIA CYTOMEGALOVIRAL 95 0.0489
35 CYTOMEGALOVIRUS TEST 2 0.0444
36 IDIOPATHIC PNEUMONIA SYNDROME 13 0.0436
37 MYCOTIC ENDOPHTHALMITIS 8 0.0423
38 ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA 2 0.0417
39 INTRAOCULAR PRESSURE TEST 10 0.0417
40 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 3 0.0411
41 NECROTISING HERPETIC RETINOPATHY 3 0.0405
42 HERPES SIMPLEX TEST POSITIVE 8 0.0402
43 DRUG RESISTANCE MUTATION 7 0.0393
44 BK VIRUS INFECTION 125 0.0370
45 THORACIC HAEMORRHAGE 7 0.0350
46 IMMUNE RECOVERY UVEITIS 2 0.0345
47 CYTOMEGALOVIRUS ENTEROCOLITIS 26 0.0338
48 ACIDOSIS HYPERCHLORAEMIC 20 0.0337
49 CYSTITIS HAEMORRHAGIC 132 0.0327
50 BRONCHIAL OEDEMA 3 0.0319
51 BLADDER HYPERTROPHY 14 0.0316
52 GLOMERULONEPHROPATHY 8 0.0312
53 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 7 0.0304
54 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 40 0.0304
55 RETINAL SCAR 14 0.0304
56 ENCEPHALITIS HERPES 15 0.0304
57 BACTEROIDES TEST POSITIVE 2 0.0303
58 CYTOMEGALOVIRUS OESOPHAGITIS 11 0.0299
59 VENOUS HAEMORRHAGE 9 0.0290
60 LIMBIC ENCEPHALITIS 8 0.0290
61 TRANSPLANT DYSFUNCTION 51 0.0286
62 MENINGOENCEPHALITIS VIRAL 5 0.0282
63 PATHOGEN RESISTANCE 249 0.0273
64 GENITAL ULCERATION 20 0.0260
65 ASPERGILLUS TEST POSITIVE 8 0.0260
66 CENTRAL NERVOUS SYSTEM NECROSIS 7 0.0254
67 DISSEMINATED VARICELLA ZOSTER VACCINE VIRUS INFECTION 2 0.0253
68 HUMAN HERPESVIRUS 7 INFECTION 2 0.0253
69 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 35 0.0248
70 CEREBRAL TOXOPLASMOSIS 23 0.0246
71 PENILE ULCERATION 8 0.0245
72 MYCOBACTERIUM KANSASII INFECTION 4 0.0244
73 CYTOMEGALOVIRUS INFECTION 396 0.0238
74 HUMAN HERPESVIRUS 6 INFECTION 45 0.0238
75 ATROPHY OF GLOBE 3 0.0234
76 CYTOMEGALOVIRUS GASTROENTERITIS 5 0.0233
77 FUNGAL ENDOCARDITIS 7 0.0233
78 CONGENITAL APLASIA 7 0.0225
79 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 16 0.0223
80 ENCEPHALITIS FUNGAL 2 0.0222
81 CYTOMEGALOVIRUS COLITIS 51 0.0222
82 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 47 0.0221
83 MUCOCUTANEOUS ULCERATION 5 0.0220
84 RETINAL ISCHAEMIA 13 0.0213
85 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 3 0.0210
86 CYSTITIS VIRAL 8 0.0209
87 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 57 0.0206
88 CSF CELL COUNT INCREASED 3 0.0203
89 DRUG RESISTANCE 520 0.0202
90 NEPHROPATHY TOXIC 227 0.0202
91 CYTOMEGALOVIRUS TEST POSITIVE 36 0.0202
92 MENINGOENCEPHALITIS HERPETIC 9 0.0201
93 SCEDOSPORIUM INFECTION 14 0.0198
94 CYTOMEGALOVIRUS HEPATITIS 7 0.0198
95 POST TRANSPLANT DISTAL LIMB SYNDROME 4 0.0197
96 CEREBRAL ASPERGILLOSIS 12 0.0195
97 BETA 2 MICROGLOBULIN INCREASED 5 0.0192
98 GENITAL LESION 8 0.0188
99 HERPES SIMPLEX REACTIVATION 7 0.0184
100 SEPTIC EMBOLUS 15 0.0180
101 EYE INFECTION TOXOPLASMAL 7 0.0176
102 HYPHAEMA 9 0.0172
103 ABSCESS FUNGAL 3 0.0172
104 ADENOVIRUS INFECTION 50 0.0172
105 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 6 0.0171
106 HERPES SIMPLEX HEPATITIS 4 0.0167
107 DISSEMINATED TOXOPLASMOSIS 2 0.0167
108 GENITOURINARY SYMPTOM 3 0.0165
109 RENAL TUBULAR INJURY 20 0.0165
110 BLOOD BETA-D-GLUCAN INCREASED 5 0.0163
111 HERPES SIMPLEX VIRAEMIA 2 0.0160
112 IRIS NEOVASCULARISATION 2 0.0160
113 ACUTE GRAFT VERSUS HOST DISEASE 73 0.0159
114 GRAFT VERSUS HOST DISEASE IN SKIN 35 0.0159
115 HIPPOCAMPAL SCLEROSIS 2 0.0156
116 DELAYED ENGRAFTMENT 2 0.0155
117 CNS VENTRICULITIS 5 0.0153
118 SCROTAL ULCER 4 0.0153
119 RENAL TUBULAR DISORDER 43 0.0153
120 INFECTION REACTIVATION 17 0.0148
121 URETHRITIS 8 0.0148
122 CHRONIC GRAFT VERSUS HOST DISEASE 53 0.0147
123 OESOPHAGITIS ULCERATIVE 10 0.0146
124 MENINGITIS VIRAL 20 0.0146
125 BOTULISM 12 0.0145
126 ADENOVIRAL HAEMORRHAGIC CYSTITIS 3 0.0144
127 LEUKAEMIC INFILTRATION 2 0.0143
128 POLYOMAVIRUS VIRAEMIA 15 0.0141
129 ENDOCARDITIS ENTEROCOCCAL 2 0.0141
130 HERPES SIMPLEX 91 0.0140
131 GRAFT VERSUS HOST DISEASE IN LIVER 10 0.0140
132 GENOTYPE DRUG RESISTANCE TEST POSITIVE 14 0.0136
133 COLORECTAL ADENOCARCINOMA 3 0.0134
134 RESPIRATORY TRACT INFECTION FUNGAL 7 0.0133
135 TRACHEITIS 10 0.0131
136 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 3 0.0130
137 PARENTERAL NUTRITION 3 0.0130
138 HAEMORRHAGIC CYST 5 0.0129
139 GRAFT VERSUS HOST DISEASE 92 0.0128
140 URAEMIC ENCEPHALOPATHY 4 0.0128
141 INTRACRANIAL MASS 12 0.0127
142 GLYCOSURIA 17 0.0126
143 CANDIDA PNEUMONIA 4 0.0124
144 PARVOVIRUS INFECTION 5 0.0124
145 ENCEPHALITIS VIRAL 15 0.0123
146 FUNGAL SEPSIS 10 0.0120
147 CORONAVIRUS PNEUMONIA 2 0.0120
148 MACULAR FIBROSIS 8 0.0118
149 NEPHROGENIC DIABETES INSIPIDUS 13 0.0113
150 CYTOMEGALOVIRUS ENTERITIS 4 0.0112
151 HERPES ZOSTER MENINGITIS 2 0.0109
152 APLASTIC ANAEMIA 57 0.0109
153 ACINETOBACTER BACTERAEMIA 2 0.0106
154 MICROANGIOPATHY 10 0.0106
155 VULVAL ULCERATION 3 0.0106
156 HAEMOFILTRATION 2 0.0105
157 ENGRAFT FAILURE 3 0.0105
158 HISTIOCYTOSIS HAEMATOPHAGIC 31 0.0104
159 LOWER RESPIRATORY TRACT INFECTION FUNGAL 4 0.0103
160 ENGRAFTMENT SYNDROME 6 0.0102
161 CRYSTAL NEPHROPATHY 6 0.0101
162 BONE MARROW TOXICITY 12 0.0101
163 ENTEROCOCCAL SEPSIS 8 0.0099
164 PNEUMONIA PSEUDOMONAL 15 0.0098
165 BACTERIAL TRANSLOCATION 3 0.0095
166 MULTIPLE-DRUG RESISTANCE 29 0.0093
167 RETINITIS 16 0.0093
168 PNEUMOCYSTIS JIROVECII INFECTION 11 0.0092
169 VARICELLA ZOSTER VIRUS INFECTION 19 0.0092
170 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE 2 0.0091
171 CEREBRAL ARTERY EMBOLISM 11 0.0090
172 ANORECTAL SWELLING 2 0.0087
173 NEUROLOGICAL DECOMPENSATION 20 0.0086
174 PYOGENIC GRANULOMA 4 0.0086
175 AMOEBIASIS 2 0.0085
176 DISSEMINATED ASPERGILLOSIS 4 0.0085
177 RETINAL VASCULITIS 10 0.0084
178 EPSTEIN-BARR VIRUS INFECTION 52 0.0083
179 GRAFT LOSS 6 0.0083
180 BLINDNESS CORTICAL 4 0.0082
181 VENOOCCLUSIVE LIVER DISEASE 40 0.0081
182 ASPERGILLUS INFECTION 53 0.0081
183 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 41 0.0080
184 HYDROURETER 3 0.0079
185 STAPHYLOCOCCAL SEPSIS 39 0.0079
186 VIRAL MUTATION IDENTIFIED 29 0.0079
187 ANAL INFECTION 2 0.0078
188 THROMBOTIC MICROANGIOPATHY 75 0.0077
189 GASTROINTESTINAL VIRAL INFECTION 8 0.0077
190 INFUSION SITE CELLULITIS 4 0.0076
191 HUMAN POLYOMAVIRUS INFECTION 4 0.0075
192 TOXOPLASMOSIS 8 0.0074
193 UREAPLASMA INFECTION 3 0.0074
194 ENCEPHALOMYELITIS 2 0.0073
195 EPIRETINAL MEMBRANE 2 0.0072
196 FUSARIUM INFECTION 5 0.0071
197 PYRAMIDAL TRACT SYNDROME 3 0.0071
198 GASTRODUODENAL ULCER 3 0.0071
199 RENAL TUBULAR DYSFUNCTION 4 0.0071
200 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 53 0.0071
201 TRANSPLANT FAILURE 17 0.0069
202 NORMOCYTIC ANAEMIA 10 0.0068
203 CANDIDA SEPSIS 6 0.0067
204 ENCEPHALITIS 46 0.0066
205 ENTEROBACTER BACTERAEMIA 2 0.0066
206 BLADDER TAMPONADE 2 0.0066
207 INFECTIVE EXACERBATION OF BRONCHIECTASIS 2 0.0065
208 VITREOUS HAEMORRHAGE 18 0.0065
209 MENINGISM 3 0.0064
210 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 2 0.0064
211 GRAFT VERSUS HOST DISEASE IN LUNG 3 0.0063
212 LIP HAEMORRHAGE 8 0.0063
213 CHORIORETINITIS 4 0.0062
214 APLASIA 12 0.0061
215 DEVICE RELATED THROMBOSIS 6 0.0061
216 INFECTIVE ANEURYSM 3 0.0061
217 CELL DEATH 12 0.0060
218 HYPERCREATINAEMIA 2 0.0060
219 PROTEIN-LOSING GASTROENTEROPATHY 3 0.0060
220 EMBOLIC CEREBRAL INFARCTION 4 0.0060
221 BRAIN HERNIATION 18 0.0060
222 GENERALISED OEDEMA 74 0.0060
223 BACTERIAL SEPSIS 19 0.0058
224 COMPUTERISED TOMOGRAM THORAX ABNORMAL 4 0.0058
225 BRONCHOPULMONARY ASPERGILLOSIS 45 0.0058
226 VIRAEMIA 8 0.0058
227 FUNGAEMIA 9 0.0057
228 ENTEROCOCCAL BACTERAEMIA 6 0.0057
229 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 10 0.0057
230 EYE SYMPTOM 2 0.0056
231 VENOOCCLUSIVE DISEASE 14 0.0056
232 HERPES ZOSTER MENINGOENCEPHALITIS 2 0.0056
233 COMPLICATIONS OF BONE MARROW TRANSPLANT 2 0.0055
234 CEREBRAL MASS EFFECT 2 0.0055
235 PLATELET TRANSFUSION 7 0.0054
236 ASPERGILLOSIS 7 0.0054
237 MULTIPLE ORGAN DYSFUNCTION SYNDROME 151 0.0053
238 LEUKAEMIA RECURRENT 9 0.0053
239 MYCOBACTERIUM AVIUM COMPLEX INFECTION 14 0.0052
240 CORNEAL EPITHELIUM DEFECT 3 0.0052
241 PANCYTOPENIA 287 0.0051
242 GRAFT COMPLICATION 3 0.0051
243 CONTINUOUS HAEMODIAFILTRATION 5 0.0051
244 HAEMORRHAGE URINARY TRACT 13 0.0051
245 ENDOCARDITIS BACTERIAL 4 0.0051
246 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 4 0.0051
247 RENAL TRANSPLANT FAILURE 5 0.0051
248 HEPATITIS FULMINANT 15 0.0051
249 ANTEROGRADE AMNESIA 3 0.0050
250 HYPOGONADISM 5 0.0049
251 RENAL ABSCESS 4 0.0049
252 OPPORTUNISTIC INFECTION 9 0.0049
253 CAPILLARY LEAK SYNDROME 10 0.0048
254 SYSTEMIC CANDIDA 12 0.0048
255 SERUM SICKNESS-LIKE REACTION 3 0.0048
256 HYPOTONY OF EYE 2 0.0048
257 HYPERCHLORAEMIA 3 0.0047
258 ESCHERICHIA BACTERAEMIA 11 0.0047
259 GLIOSIS 2 0.0047
260 STAPHYLOCOCCAL ABSCESS 3 0.0047
261 IMMUNE RECONSTITUTION SYNDROME 6 0.0046
262 PULMONARY ALVEOLAR HAEMORRHAGE 26 0.0046
263 HEPATIC NECROSIS 17 0.0045
264 ESCHERICHIA SEPSIS 13 0.0045
265 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 2 0.0044
266 RETINAL DETACHMENT 40 0.0043
267 BRAIN ABSCESS 11 0.0043
268 HERPES SIMPLEX ENCEPHALITIS 2 0.0043
269 MYELOSUPPRESSION 155 0.0043
270 SYSTEMIC MYCOSIS 5 0.0043
271 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
272 MECHANICAL VENTILATION 8 0.0042
273 VIRAL LOAD INCREASED 16 0.0041
274 CARDIAC VALVE VEGETATION 2 0.0041
275 ESCHAR 3 0.0041
276 BLOOD AMYLASE INCREASED 7 0.0041
277 PNEUMONIA VIRAL 13 0.0041
278 ENDOCARDITIS STAPHYLOCOCCAL 2 0.0041
279 ELECTROLYTE DEPLETION 2 0.0040
280 HYPERCREATININAEMIA 2 0.0040
281 BRAIN DEATH 12 0.0039
282 HYPOMAGNESAEMIA 54 0.0039
283 ELECTROLYTE IMBALANCE 45 0.0039
284 CEREBRAL HAEMATOMA 13 0.0039
285 CEREBRAL VENOUS THROMBOSIS 7 0.0039
286 PULMONARY MYCOSIS 3 0.0039
287 FAECAL VOLUME INCREASED 2 0.0038
288 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 3 0.0038
289 BLOOD ALBUMIN ABNORMAL 2 0.0038
290 METAPNEUMOVIRUS INFECTION 3 0.0038
291 OBLITERATIVE BRONCHIOLITIS 5 0.0038
292 PNEUMONIA FUNGAL 15 0.0038
293 HERPES OPHTHALMIC 5 0.0038
294 TRANSPLANT REJECTION 30 0.0037
295 HERPES ZOSTER DISSEMINATED 3 0.0037
296 ANAL ULCER 3 0.0037
297 BLOOD MAGNESIUM ABNORMAL 2 0.0036
298 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 18 0.0036
299 STEM CELL TRANSPLANT 9 0.0036
300 BONE MARROW FAILURE 73 0.0036
301 RESPIRATORY DISTRESS 99 0.0036
302 TOXIC EPIDERMAL NECROLYSIS 54 0.0036
303 FANCONI SYNDROME 5 0.0035
304 BLADDER TRANSITIONAL CELL CARCINOMA 5 0.0035
305 COLON INJURY 2 0.0035
306 ORGAN FAILURE 14 0.0035
307 MULTI-ORGAN FAILURE 60 0.0035
308 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
309 ORGANISING PNEUMONIA 17 0.0034
310 PULMONARY HAEMORRHAGE 26 0.0033
311 HYPOGLYCAEMIC SEIZURE 3 0.0033
312 MUCOSAL EROSION 3 0.0033
313 DISSEMINATED INTRAVASCULAR COAGULATION 46 0.0033
314 CYTOPENIA 40 0.0033
315 LYMPHOPENIA 46 0.0032
316 HYPOPHOSPHATAEMIA 24 0.0032
317 PUPILLARY REFLEX IMPAIRED 6 0.0032
318 VITRITIS 6 0.0032
319 BLOOD ELECTROLYTES ABNORMAL 4 0.0032
320 HYPOGAMMAGLOBULINAEMIA 21 0.0032
321 CORNEAL DISORDER 7 0.0032
322 CYSTOID MACULAR OEDEMA 6 0.0032
323 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
324 RENAL IMPAIRMENT 263 0.0031
325 GUILLAIN-BARRE SYNDROME 15 0.0031
326 KLEBSIELLA TEST POSITIVE 2 0.0031
327 CHONDROCALCINOSIS 2 0.0031
328 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 18 0.0030
329 LUNG TRANSPLANT REJECTION 2 0.0030
330 GENE MUTATION 6 0.0030
331 HYPOFIBRINOGENAEMIA 3 0.0030
332 OESOPHAGEAL CANDIDIASIS 12 0.0030
333 KLEBSIELLA INFECTION 15 0.0030
334 LEUKOENCEPHALOPATHY 11 0.0030
335 STENOTROPHOMONAS INFECTION 4 0.0029
336 HYDROCEPHALUS 16 0.0029
337 PSEUDOMONAS INFECTION 25 0.0029
338 BLAST CELL COUNT INCREASED 3 0.0029
339 PSEUDOMONAL SEPSIS 5 0.0029
340 MUCOSAL INFLAMMATION 74 0.0028
341 ACUTE MYELOID LEUKAEMIA RECURRENT 6 0.0028
342 BACTERAEMIA 33 0.0028
343 BLOOD HIV RNA INCREASED 5 0.0028
344 RENAL TUBULAR ACIDOSIS 6 0.0027
345 SUBRETINAL FLUID 3 0.0027
346 CORNEAL DEPOSITS 2 0.0027
347 RETINAL HAEMORRHAGE 19 0.0027
348 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
349 CALCULUS URINARY 4 0.0026
350 FOLATE DEFICIENCY 3 0.0026
351 RHINOVIRUS INFECTION 10 0.0026
352 CHRONIC ALLOGRAFT NEPHROPATHY 2 0.0026
353 HEPATOMEGALY 25 0.0025
354 NON-CARDIAC CHEST PAIN 8 0.0025
355 JC VIRUS INFECTION 4 0.0025
356 CREATININE RENAL CLEARANCE DECREASED 10 0.0025
357 HEPATITIS VIRAL 2 0.0025
358 DIABETES INSIPIDUS 6 0.0025
359 ACUTE LYMPHOCYTIC LEUKAEMIA 7 0.0025
360 CHRONIC HEPATITIS 2 0.0025
361 BASAL GANGLIA HAEMORRHAGE 2 0.0025
362 SPLENIC RUPTURE 4 0.0024
363 HYPERURICAEMIA 10 0.0024
364 VIROLOGIC FAILURE 13 0.0024
365 CAMPYLOBACTER INFECTION 2 0.0024
366 IMMUNE THROMBOCYTOPENIA 11 0.0024
367 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
368 BRONCHIAL SECRETION RETENTION 3 0.0024
369 HAEMATOTOXICITY 22 0.0023
370 FOOD REFUSAL 2 0.0023
371 HYPERLEUKOCYTOSIS 2 0.0023
372 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
373 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
374 HYPERPLASIA 2 0.0022
375 HYPOCALCAEMIA 42 0.0022
376 OPHTHALMIC HERPES ZOSTER 4 0.0022
377 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
378 HEPATIC FAILURE 66 0.0022
379 CHOLESTASIS 42 0.0022
380 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
381 ACUTE KIDNEY INJURY 328 0.0021
382 BRAIN STEM HAEMORRHAGE 2 0.0021
383 BONE MARROW TRANSPLANT 4 0.0021
384 KLEBSIELLA BACTERAEMIA 2 0.0021
385 NEUROLOGICAL SYMPTOM 12 0.0021
386 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
387 BONE MARROW DEPRESSION 2 0.0020
388 HYPERVOLAEMIA 10 0.0020
389 SEPTIC SHOCK 86 0.0020
390 INTRACRANIAL PRESSURE INCREASED 11 0.0020
391 MACULAR OEDEMA 11 0.0020
392 UVEITIS 26 0.0019
393 OPHTHALMOPLEGIA 3 0.0019
394 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
395 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 18 0.0019
396 PNEUMONIA LEGIONELLA 3 0.0019
397 PULMONARY TUBERCULOSIS 8 0.0019
398 CD4 LYMPHOCYTES DECREASED 4 0.0019
399 ENTEROCOCCAL INFECTION 9 0.0019
400 KIDNEY ENLARGEMENT 2 0.0018
401 PULMONARY TOXICITY 13 0.0018
402 HYPOALBUMINAEMIA 14 0.0018
403 LUNG CONSOLIDATION 5 0.0018
404 ENDOTRACHEAL INTUBATION 5 0.0018
405 RESPIRATORY FAILURE 130 0.0018
406 MENINGITIS ASEPTIC 8 0.0018
407 CANDIDA INFECTION 30 0.0018
408 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 96 0.0017
409 LEUKOPENIA 87 0.0017
410 CEREBRAL VENTRICLE DILATATION 2 0.0017
411 HERPES VIRUS INFECTION 10 0.0017
412 KIDNEY FIBROSIS 3 0.0017
413 VASCULAR PSEUDOANEURYSM 3 0.0017
414 HYPOKALAEMIA 79 0.0017
415 HYPORESPONSIVE TO STIMULI 2 0.0017
416 PNEUMOMEDIASTINUM 3 0.0017
417 HEPATIC PAIN 7 0.0016
418 PNEUMONIA KLEBSIELLA 3 0.0016
419 RENAL TUBULAR NECROSIS 16 0.0016
420 HYPERNATRAEMIA 8 0.0016
421 ORAL CANDIDIASIS 21 0.0016
422 ELECTROENCEPHALOGRAM ABNORMAL 5 0.0016
423 BRAIN OEDEMA 20 0.0016
424 HYPOPROTEINAEMIA 3 0.0016
425 HAEMATURIA 54 0.0016
426 RETINAL OEDEMA 3 0.0016
427 HEPATOSPLENOMEGALY 4 0.0016
428 CEREBRAL ISCHAEMIA 8 0.0016
429 HAEMOLYSIS 12 0.0016
430 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
431 HYPERBILIRUBINAEMIA 16 0.0015
432 HEPATITIS ACUTE 10 0.0015
433 ENCEPHALITIS AUTOIMMUNE 2 0.0015
434 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
435 ODYNOPHAGIA 9 0.0015
436 ACUTE RESPIRATORY FAILURE 29 0.0015
437 DEVICE RELATED SEPSIS 3 0.0015
438 GAMMA-GLUTAMYLTRANSFERASE INCREASED 33 0.0015
439 NEUTROPENIA 199 0.0015
440 KIDNEY TRANSPLANT REJECTION 7 0.0015
441 CENTRAL NERVOUS SYSTEM LESION 20 0.0015
442 HAEMOLYTIC ANAEMIA 13 0.0014
443 BILIARY TRACT DISORDER 2 0.0014
444 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
445 HYPERPHOSPHATAEMIA 3 0.0014
446 LUNG DISORDER 68 0.0014
447 LEUKAEMIA 13 0.0014
448 SCLERODERMA 5 0.0014
449 CEREBRAL HAEMORRHAGE 48 0.0013
450 STATUS EPILEPTICUS 15 0.0013
451 PERIARTHRITIS 3 0.0013
452 HAEMODIALYSIS 11 0.0013
453 GENITAL HERPES 2 0.0013
454 PNEUMONIA BACTERIAL 12 0.0013
455 ENCEPHALOPATHY 32 0.0013
456 METHAEMOGLOBINAEMIA 3 0.0013
457 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
458 BILIRUBIN CONJUGATED INCREASED 3 0.0013
459 IRIDOCYCLITIS 4 0.0013
460 PNEUMOTHORAX 20 0.0013
461 VENTRICULAR FIBRILLATION 14 0.0013
462 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
463 PNEUMONITIS 34 0.0012
464 IMMUNOSUPPRESSION 11 0.0012
465 CANDIDIASIS 5 0.0012
466 LYMPHADENITIS 3 0.0012
467 FEBRILE NEUTROPENIA 81 0.0012
468 RETINAL TEAR 3 0.0012
469 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 10 0.0012
470 CYTOLYTIC HEPATITIS 4 0.0012
471 ASCITES 35 0.0012
472 ENTEROBACTER INFECTION 2 0.0012
473 FEBRILE BONE MARROW APLASIA 5 0.0012
474 ENDOPHTHALMITIS 7 0.0012
475 BLOOD CHLORIDE DECREASED 3 0.0012
476 MALNUTRITION 13 0.0012
477 ACUTE SINUSITIS 2 0.0012
478 THERAPY NON-RESPONDER 52 0.0012
479 MUCORMYCOSIS 3 0.0012
480 RETINAL DISORDER 3 0.0012
481 HEPATIC FUNCTION ABNORMAL 43 0.0012
482 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
483 BLOOD BILIRUBIN INCREASED 31 0.0011
484 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
485 BLOOD CREATINE INCREASED 5 0.0011
486 RENAL FAILURE 149 0.0011
487 PRODUCT SUPPLY ISSUE 8 0.0011
488 ILEUS PARALYTIC 5 0.0011
489 LIVER TRANSPLANT REJECTION 2 0.0011
490 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
491 SHOCK HAEMORRHAGIC 9 0.0011
492 LARGE INTESTINAL ULCER 3 0.0011
493 CYTOKINE RELEASE SYNDROME 22 0.0011
494 UROSEPSIS 10 0.0011
495 AGRANULOCYTOSIS 20 0.0011
496 INTERSTITIAL LUNG DISEASE 52 0.0011
497 THROMBOCYTOPENIA 120 0.0011
498 NEPHROPATHY 10 0.0011
499 PSYCHOMOTOR RETARDATION 3 0.0011
500 PNEUMATOSIS INTESTINALIS 3 0.0011
501 CARDIAC FAILURE ACUTE 7 0.0010
502 HAEMODYNAMIC INSTABILITY 8 0.0010
503 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
504 MYOCARDITIS 12 0.0010
505 HYPOVOLAEMIC SHOCK 5 0.0010
506 HYPOREFLEXIA 2 0.0010
507 ENTEROCOLITIS 6 0.0010
508 RENAL FAILURE ACUTE 44 0.0010
509 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
510 FUNGAL INFECTION 34 0.0010
511 RESPIRATORY ACIDOSIS 4 0.0010
512 OFF LABEL USE 890 0.0010
513 BLOOD UREA INCREASED 17 0.0010
514 HYPERLIPIDAEMIA 12 0.0010
515 CEREBRAL ATROPHY 4 0.0010
516 SHOCK 23 0.0010
517 HEPATOCELLULAR INJURY 14 0.0010
518 CACHEXIA 5 0.0010
519 METABOLIC ACIDOSIS 31 0.0010
520 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
521 BACTERIAL INFECTION 18 0.0010
522 LIVEDO RETICULARIS 2 0.0010
523 MOUTH HAEMORRHAGE 7 0.0010
524 DILATATION VENTRICULAR 2 0.0010
525 PERICARDIAL EFFUSION 22 0.0010
526 SERUM FERRITIN INCREASED 5 0.0009
527 SKIN EROSION 3 0.0009
528 BLOOD CREATININE INCREASED 60 0.0009
529 DIFFUSE LARGE B-CELL LYMPHOMA 7 0.0009
530 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
531 LUNG INFILTRATION 8 0.0009
532 HEPATITIS 23 0.0009
533 CHOLESTATIC LIVER INJURY 2 0.0009
534 HEMIPARESIS 15 0.0009
535 SUSPECTED OFF LABEL USE 4 0.0009
536 DISTRIBUTIVE SHOCK 2 0.0009
537 APLASIA PURE RED CELL 3 0.0009
538 COLITIS 33 0.0009
539 HYPERTRANSAMINASAEMIA 6 0.0009
540 RENAL FUNCTION TEST ABNORMAL 4 0.0009
541 TRANSFUSION 9 0.0009
542 PLEURAL EFFUSION 52 0.0009
543 SEPSIS 91 0.0008
544 HYPERCALCAEMIA 10 0.0008
545 INFLAMMATORY MARKER INCREASED 4 0.0008
546 CARDIAC DYSFUNCTION 3 0.0008
547 DERMATOMYOSITIS 2 0.0008
548 ABDOMINAL INFECTION 2 0.0008
549 OESOPHAGEAL ULCER 3 0.0008
550 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
551 LYMPHOMA 12 0.0008
552 TREATMENT FAILURE 64 0.0008
553 CARDIOPULMONARY FAILURE 3 0.0008
554 BLOOD LACTIC ACID INCREASED 4 0.0008
555 POLYDIPSIA 3 0.0008
556 LUNG OPACITY 2 0.0008
557 GRAND MAL CONVULSION 7 0.0008
558 GASTROENTERITIS 11 0.0008
559 BLOOD POTASSIUM ABNORMAL 2 0.0007
560 AREFLEXIA 2 0.0007
561 HAEMORRHAGE INTRACRANIAL 11 0.0007
562 DEMYELINATION 3 0.0007
563 ESCHERICHIA INFECTION 6 0.0007
564 LIVER FUNCTION TEST ABNORMAL 21 0.0007
565 COAGULOPATHY 12 0.0007
566 LIVE BIRTH 6 0.0007
567 RENAL DISORDER 33 0.0007
568 DIALYSIS 10 0.0007
569 PRODUCT USE ISSUE 132 0.0007
570 NEUTROPENIC SEPSIS 5 0.0007
571 MYOPATHY 6 0.0007
572 MYELODYSPLASTIC SYNDROME 10 0.0007
573 BONE CANCER 3 0.0007
574 SUBARACHNOID HAEMORRHAGE 7 0.0007
575 NEUROTOXICITY 12 0.0007
576 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
577 STOMATITIS 41 0.0007
578 MYOCLONUS 8 0.0007
579 PULMONARY OEDEMA 30 0.0007
580 ATYPICAL PNEUMONIA 2 0.0007
581 STAPHYLOCOCCAL INFECTION 22 0.0007
582 VENTRICULAR TACHYCARDIA 11 0.0007
583 HEPATITIS CHOLESTATIC 4 0.0007
584 HIV INFECTION 2 0.0007
585 BONE MARROW DISORDER 2 0.0007
586 VASCULAR DEVICE INFECTION 3 0.0007
587 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
588 INTRACARDIAC THROMBUS 2 0.0007
589 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
590 ACUTE MYELOID LEUKAEMIA 10 0.0006
591 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
592 BLOOD CREATININE DECREASED 2 0.0006
593 HYPERKALAEMIA 22 0.0006
594 CUSHINGOID 2 0.0006
595 DRUG ERUPTION 11 0.0006
596 LIVER ABSCESS 2 0.0006
597 DECREASED IMMUNE RESPONSIVENESS 6 0.0006
598 POLYURIA 5 0.0006
599 HYPERAMMONAEMIA 3 0.0006
600 DERMATITIS EXFOLIATIVE 3 0.0006
601 TOXIC ENCEPHALOPATHY 3 0.0006
602 ULCER HAEMORRHAGE 4 0.0006
603 EYELID PTOSIS 6 0.0006
604 OEDEMA 32 0.0006
605 PRODUCT USE IN UNAPPROVED INDICATION 145 0.0006
606 BRONCHOPNEUMONIA 2 0.0006
607 NEPHROTIC SYNDROME 4 0.0006
608 HEPATIC FIBROSIS 2 0.0006
609 FOETAL DEATH 3 0.0006
610 FAILURE TO THRIVE 3 0.0006
611 PERIORBITAL OEDEMA 3 0.0006
612 C-REACTIVE PROTEIN INCREASED 21 0.0006
613 PARTIAL SEIZURES 3 0.0006
614 INTENTIONAL PRODUCT USE ISSUE 50 0.0006
615 DYSURIA 21 0.0006
616 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
617 HYPOXIA 20 0.0006
618 ORAL HERPES 11 0.0006
619 GLOSSITIS 2 0.0006
620 VISUAL FIELD DEFECT 4 0.0006
621 MUSCLE ATROPHY 7 0.0006
622 FLUID OVERLOAD 8 0.0005
623 HEPATIC CYTOLYSIS 7 0.0005
624 BLOOD PHOSPHORUS DECREASED 2 0.0005
625 CARDIAC ARREST 45 0.0005
626 INTESTINAL ISCHAEMIA 3 0.0005
627 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
628 PYREXIA 187 0.0005
629 HEPATOTOXICITY 12 0.0005
630 IMMUNODEFICIENCY 8 0.0005
631 ANGIOPATHY 3 0.0005
632 ACUTE PULMONARY OEDEMA 3 0.0005
633 HYPONATRAEMIA 30 0.0005
634 ARTERIOSCLEROSIS 5 0.0005
635 IMMUNE SYSTEM DISORDER 7 0.0005
636 EPILEPSY 16 0.0005
637 RENAL FAILURE CHRONIC 4 0.0005
638 SINUS BRADYCARDIA 5 0.0005
639 NERVOUS SYSTEM DISORDER 16 0.0005
640 ACUTE HEPATIC FAILURE 7 0.0005
641 TORSADE DE POINTES 4 0.0005
642 VITREOUS FLOATERS 5 0.0005
643 DISEASE PROGRESSION 60 0.0005
644 MELAENA 11 0.0005
645 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
646 HYPOTHERMIA 5 0.0005
647 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
648 BLINDNESS 20 0.0005
649 GASTROINTESTINAL HAEMORRHAGE 41 0.0005
650 DRUG INEFFECTIVE 644 0.0005
651 CONDITION AGGRAVATED 147 0.0005
652 MOUTH ULCERATION 10 0.0005
653 LIVER DISORDER 21 0.0005
654 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
655 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
656 CIRCULATORY COLLAPSE 8 0.0005
657 ENTERITIS 3 0.0005
658 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
659 PROCTALGIA 3 0.0005
660 ANURIA 4 0.0005
661 ANAEMIA 88 0.0005
662 LUNG INFECTION 7 0.0005
663 MENINGITIS 3 0.0004
664 INTESTINAL PERFORATION 5 0.0004
665 PANCREATITIS ACUTE 10 0.0004
666 NEUTROPHIL COUNT DECREASED 18 0.0004
667 PNEUMONIA ASPIRATION 11 0.0004
668 OPTIC NEURITIS 4 0.0004
669 MENTAL STATUS CHANGES 12 0.0004
670 PULMONARY HYPERTENSION 9 0.0004
671 LARGE INTESTINE PERFORATION 3 0.0004
672 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
673 HEPATIC ENCEPHALOPATHY 4 0.0004
674 PNEUMONIA 137 0.0004
675 DRUG LEVEL INCREASED 7 0.0004
676 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
677 CARDIAC TAMPONADE 2 0.0004
678 PROTEINURIA 8 0.0004
679 CONVULSION 24 0.0004
680 GASTROINTESTINAL TOXICITY 2 0.0004
681 GLAUCOMA 8 0.0004
682 ORAL DISORDER 3 0.0004
683 BREATH SOUNDS ABNORMAL 2 0.0004
684 DIABETIC NEUROPATHY 2 0.0004
685 ABDOMINAL TENDERNESS 2 0.0004
686 HYDRONEPHROSIS 3 0.0004
687 RESPIRATORY ARREST 11 0.0004
688 EMPHYSEMA 4 0.0004
689 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
690 HYPERTHERMIA 3 0.0004
691 ACIDOSIS 3 0.0004
692 LIPASE INCREASED 3 0.0004
693 VISUAL ACUITY REDUCED 13 0.0004
694 ENDOCARDITIS 2 0.0004
695 SEIZURE 45 0.0004
696 BLOOD ALBUMIN DECREASED 3 0.0004
697 COMA 18 0.0004
698 EATING DISORDER 8 0.0004
699 BLOOD DISORDER 3 0.0004
700 LACTIC ACIDOSIS 12 0.0004
701 WHITE BLOOD CELL COUNT DECREASED 40 0.0004
702 PLATELET COUNT DECREASED 39 0.0004
703 SKIN LESION 10 0.0004
704 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
705 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
706 HEMIPLEGIA 3 0.0004
707 VIRAL INFECTION 12 0.0004
708 TRANSAMINASES INCREASED 8 0.0004
709 RASH MACULO-PAPULAR 8 0.0004
710 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
711 INTERMENSTRUAL BLEEDING 2 0.0004
712 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
713 SKIN INFECTION 4 0.0004
714 SINUS TACHYCARDIA 5 0.0004
715 FACIAL PARALYSIS 3 0.0004
716 GRANULOCYTOPENIA 2 0.0004
717 SUBDURAL HAEMATOMA 5 0.0003
718 SKIN HYPERPIGMENTATION 3 0.0003
719 HERPES ZOSTER 20 0.0003
720 BLOOD MAGNESIUM DECREASED 3 0.0003
721 BLOOD URIC ACID INCREASED 2 0.0003
722 PYELONEPHRITIS 3 0.0003
723 INFECTION 50 0.0003
724 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
725 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
726 TUMOUR LYSIS SYNDROME 3 0.0003
727 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
728 COVID-19 PNEUMONIA 4 0.0003
729 ATAXIA 4 0.0003
730 DISEASE RECURRENCE 16 0.0003
731 ANAL INCONTINENCE 3 0.0003
732 HYPERGLYCAEMIA 12 0.0003
733 DISORIENTATION 13 0.0003
734 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
735 HYPOTENSION 65 0.0003
736 CHOLANGITIS 2 0.0003
737 ILEUS 4 0.0003
738 DRUG INTERACTION 51 0.0003
739 THERAPY PARTIAL RESPONDER 5 0.0003
740 STEVENS-JOHNSON SYNDROME 7 0.0003
741 HAEMOGLOBIN ABNORMAL 2 0.0003
742 CARDIO-RESPIRATORY ARREST 13 0.0003
743 ATELECTASIS 3 0.0003
744 ANOREXIA 4 0.0003
745 PULMONARY CONGESTION 4 0.0003
746 BLADDER DISORDER 3 0.0003
747 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
748 PERICARDITIS 5 0.0003
749 BRONCHIECTASIS 2 0.0003
750 TOXICITY TO VARIOUS AGENTS 50 0.0003
751 TASTE DISORDER 6 0.0003
752 DRUG TOXICITY 4 0.0003
753 ECCHYMOSIS 2 0.0003
754 POLLAKIURIA 12 0.0003
755 HALLUCINATION, VISUAL 6 0.0003
756 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
757 DRUG INTOLERANCE 27 0.0003
758 PARALYSIS 4 0.0003
759 DERMATITIS BULLOUS 2 0.0003
760 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
761 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
762 RESPIRATORY DISORDER 8 0.0003
763 GASTRITIS 7 0.0003
764 GASTRIC ULCER 5 0.0003
765 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
766 JAUNDICE 7 0.0003
767 CONFUSIONAL STATE 42 0.0003
768 DELIRIUM 9 0.0003
769 VASCULITIS 3 0.0003
770 ATRIAL FIBRILLATION 25 0.0003
771 SPLENOMEGALY 3 0.0003
772 GASTROINTESTINAL INFLAMMATION 2 0.0003
773 HAEMATOCRIT DECREASED 5 0.0003
774 POLYNEUROPATHY 3 0.0003
775 FULL BLOOD COUNT DECREASED 5 0.0002
776 ADRENAL INSUFFICIENCY 3 0.0002
777 NO THERAPEUTIC RESPONSE 3 0.0002
778 CEREBRAL INFARCTION 6 0.0002
779 ASPHYXIA 2 0.0002
780 RED BLOOD CELL COUNT DECREASED 7 0.0002
781 SMALL INTESTINAL OBSTRUCTION 3 0.0002
782 PERITONITIS 5 0.0002
783 EMBOLISM 2 0.0002
784 HAEMORRHAGE 25 0.0002
785 CARDIAC FAILURE 19 0.0002
786 INTRAOCULAR PRESSURE INCREASED 3 0.0002
787 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
788 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
789 BLOOD CALCIUM INCREASED 2 0.0002
790 LYMPHOCYTE COUNT DECREASED 4 0.0002
791 HAEMOGLOBIN DECREASED 23 0.0002
792 ORAL PAIN 5 0.0002
793 NEUROPATHY PERIPHERAL 21 0.0002
794 TACHYPNOEA 3 0.0002
795 END STAGE RENAL DISEASE 4 0.0002
796 GENERAL PHYSICAL HEALTH DETERIORATION 25 0.0002
797 APPENDICITIS 2 0.0002
798 DIARRHOEA HAEMORRHAGIC 2 0.0002
799 FLANK PAIN 2 0.0002
800 PHOTOPHOBIA 4 0.0002
801 HALLUCINATION 16 0.0002
802 BLOOD SODIUM DECREASED 4 0.0002
803 CHRONIC KIDNEY DISEASE 16 0.0002
804 DIARRHOEA 131 0.0002
805 DYSGEUSIA 15 0.0002
806 VISUAL IMPAIRMENT 25 0.0002
807 INABILITY TO AFFORD MEDICATION 2 0.0002
808 EPISTAXIS 15 0.0002
809 BLOOD POTASSIUM DECREASED 6 0.0002
810 HYPERTENSION 42 0.0002
811 LYMPHADENOPATHY 7 0.0002
812 DRY THROAT 2 0.0002
813 DRUG LEVEL DECREASED 2 0.0002
814 EXPOSURE DURING PREGNANCY 12 0.0002
815 GASTROINTESTINAL DISORDER 17 0.0002
816 RETCHING 4 0.0002
817 THROMBOSIS 15 0.0002
818 LIVER FUNCTION TEST INCREASED 4 0.0002
819 BLOOD POTASSIUM INCREASED 3 0.0002
820 ASPIRATION 2 0.0002
821 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
822 HAEMOPTYSIS 5 0.0002
823 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
824 BLOOD CALCIUM DECREASED 2 0.0002
825 FLUID RETENTION 9 0.0002
826 NEPHROLITHIASIS 8 0.0002
827 EYELID OEDEMA 2 0.0002
828 EOSINOPHILIA 3 0.0002
829 PANCREATITIS 9 0.0002
830 URINARY INCONTINENCE 5 0.0002
831 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
832 CHOLECYSTITIS 2 0.0002
833 RASH ERYTHEMATOUS 8 0.0002
834 OSTEOMYELITIS 3 0.0002
835 APHASIA 5 0.0002
836 AGITATION 12 0.0002
837 LIVER INJURY 4 0.0002
838 BLISTER 9 0.0002
839 TACHYCARDIA 14 0.0002
840 HYPOPHAGIA 4 0.0002
841 SEROTONIN SYNDROME 3 0.0002
842 UNRESPONSIVE TO STIMULI 4 0.0002
843 DISABILITY 3 0.0002
844 SPINAL FRACTURE 3 0.0001
845 VOMITING 69 0.0001
846 TREATMENT NONCOMPLIANCE 8 0.0001
847 OSTEOPOROSIS 6 0.0001
848 COORDINATION ABNORMAL 2 0.0001
849 BLINDNESS UNILATERAL 2 0.0001
850 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
851 CELLULITIS 7 0.0001
852 PRODUCT PRESCRIBING ISSUE 3 0.0001
853 ACCIDENTAL OVERDOSE 5 0.0001
854 RESTLESSNESS 5 0.0001
855 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
856 PARAESTHESIA 21 0.0001
857 CHROMATURIA 3 0.0001
858 DYSARTHRIA 5 0.0001
859 MUSCULAR WEAKNESS 15 0.0001
860 DEVICE RELATED INFECTION 2 0.0001
861 EJECTION FRACTION DECREASED 2 0.0001
862 COGNITIVE DISORDER 6 0.0001
863 RASH 56 0.0001
864 DRUG-INDUCED LIVER INJURY 4 0.0001
865 ABNORMAL BEHAVIOUR 5 0.0001
866 MENTAL IMPAIRMENT 3 0.0001
867 NEURALGIA 3 0.0001
868 URINARY TRACT INFECTION 21 0.0001
869 OEDEMA PERIPHERAL 15 0.0001
870 EXTRAPYRAMIDAL DISORDER 3 0.0001
871 BLOOD PRESSURE DECREASED 8 0.0001
872 URINARY RETENTION 4 0.0001
873 FACE OEDEMA 2 0.0001
874 HAEMATEMESIS 3 0.0001
875 DIABETES MELLITUS 9 0.0001
876 HEPATIC ENZYME INCREASED 8 0.0001
877 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
878 IRRITABILITY 7 0.0001
879 ABDOMINAL PAIN 27 0.0001
880 BRADYCARDIA 6 0.0001
881 GOUT 2 0.0001
882 BONE DISORDER 2 0.0001
883 HAEMATOCHEZIA 6 0.0001
884 DEEP VEIN THROMBOSIS 7 0.0001
885 DECREASED APPETITE 25 0.0001
886 WEIGHT DECREASED 30 0.0001
887 HEPATIC STEATOSIS 2 0.0001
888 OXYGEN SATURATION DECREASED 6 0.0001
889 INFUSION RELATED REACTION 7 0.0001
890 HAEMORRHOIDS 2 0.0001
891 MEMORY IMPAIRMENT 14 0.0001
892 RENAL INJURY 3 0.0001
893 CATARACT 6 0.0001
894 THERAPEUTIC RESPONSE DECREASED 6 0.0001
895 FEEDING DISORDER 2 0.0001
896 UNDERDOSE 7 0.0001
897 CYSTITIS 3 0.0001
898 WEIGHT INCREASED 21 0.0001
899 JOINT INJURY 2 0.0001
900 OVERDOSE 20 0.0001
901 AMNESIA 6 0.0001
902 MENTAL DISORDER 4 0.0001
903 CHOLELITHIASIS 3 0.0001
904 MEDICATION ERROR 5 0.0001
905 VISION BLURRED 12 0.0001
906 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
907 NEOPLASM PROGRESSION 3 0.0001
908 ABDOMINAL DISTENSION 9 0.0001
909 LOSS OF CONSCIOUSNESS 11 0.0001
910 CHILLS 10 0.0001
911 SOMNOLENCE 17 0.0001
912 DYSPHAGIA 8 0.0001
913 DEATH 70 0.0001
914 BALANCE DISORDER 7 0.0001
915 NAUSEA 64 0.0001
916 MUSCULOSKELETAL STIFFNESS 7 0.0001
917 DYSPNOEA EXERTIONAL 3 0.0001
918 SINUSITIS 8 0.0001
919 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
920 ABDOMINAL DISCOMFORT 13 0.0001
921 DIPLOPIA 2 0.0001
922 CEREBROVASCULAR ACCIDENT 13 0.0001
923 OROPHARYNGEAL PAIN 7 0.0001
924 CARDIAC FAILURE CONGESTIVE 6 0.0001
925 DYSKINESIA 3 0.0001
926 TREMOR 12 0.0001
927 DIVERTICULITIS 2 0.0001
928 INFLUENZA 8 0.0001
929 RECTAL HAEMORRHAGE 3 0.0001
930 LETHARGY 4 0.0001
931 COVID-19 12 0.0001
932 ACUTE MYOCARDIAL INFARCTION 2 0.0001
933 LABORATORY TEST ABNORMAL 2 0.0001
934 COUGH 19 0.0001
935 DEHYDRATION 9 0.0001
936 ILL-DEFINED DISORDER 4 0.0001
937 DYSPNOEA 37 0.0001
938 ARRHYTHMIA 3 0.0001
939 IMPAIRED HEALING 2 0.0001
940 EYE DISORDER 2 0.0001
941 HEADACHE 37 0.0001
942 GASTRIC DISORDER 2 0.0001
943 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
944 DRUG EFFECT DECREASED 3 0.0001
945 NO ADVERSE EVENT 10 0.0001
946 ANAPHYLACTIC REACTION 3 0.0001
947 CHEST PAIN 10 0.0001
948 ERYTHEMA 11 0.0001
949 HYPOAESTHESIA 8 0.0001
950 INTESTINAL OBSTRUCTION 2 0.0001
951 PERIPHERAL SWELLING 8 0.0001
952 SYNCOPE 5 0.0000
953 CHEST DISCOMFORT 5 0.0000
954 ASTHENIA 18 0.0000
955 HYPERHIDROSIS 6 0.0000
956 HYPOACUSIS 2 0.0000
957 PAIN 28 0.0000
958 COLITIS ULCERATIVE 2 0.0000
959 CARDIAC DISORDER 4 0.0000
960 PULMONARY EMBOLISM 4 0.0000
961 THERAPY INTERRUPTED 3 0.0000
962 FLUSHING 4 0.0000
963 HOSPITALISATION 6 0.0000
964 INFLAMMATION 2 0.0000
965 DISTURBANCE IN ATTENTION 2 0.0000
966 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
967 PRURITUS 14 0.0000
968 MYOCARDIAL INFARCTION 6 0.0000
969 INTENTIONAL PRODUCT MISUSE 3 0.0000
970 PALPITATIONS 4 0.0000
971 FALL 11 0.0000
972 BLOOD PRESSURE INCREASED 5 0.0000
973 ADVERSE EVENT 3 0.0000
974 CONSTIPATION 7 0.0000
975 MALAISE 14 0.0000
976 DRY SKIN 4 0.0000
977 ASTHMA 3 0.0000
978 BACK PAIN 6 0.0000
979 FATIGUE 20 0.0000
980 ABDOMINAL PAIN UPPER 5 0.0000
981 DIZZINESS 11 0.0000
982 HYPERSENSITIVITY 4 0.0000
983 GAIT DISTURBANCE 4 0.0000
984 CONTUSION 2 0.0000
985 ILLNESS 2 0.0000
986 URTICARIA 3 0.0000
987 INCORRECT DOSE ADMINISTERED 4 0.0000
988 PAIN IN EXTREMITY 5 0.0000
989 INSOMNIA 4 0.0000
990 ANXIETY 4 0.0000
991 DEPRESSION 3 0.0000
992 FEELING ABNORMAL 3 0.0000
993 BLOOD GLUCOSE INCREASED 2 0.0000
994 ALOPECIA 2 0.0000
995 ARTHRALGIA 3 0.0000